VC firms
Edit

Adage Capital Management

https://adagecapital.com/
Last activity: 10.08.2026
Active
Portfolio
3
Mentions
23

Overview

Investment Stage
Series B; Series E

Portfolio 3

DateNameWebsiteTotal RaisedLocation
Sign up to seeSign up to seeSign up to seeSign up to seeSign up to see
Sep 10, 2025PsiQuantumpsiquantum.com$2.82BUnited States
Aug 11, 2025Equilliumequilliumbio.com$50MUnited States, California, San Diego

Mentions in press and media 23

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Aug 9, 2026Expedition Therapeutics Lands $115M Series B SAN FRANCISCO, CA, Expedition Therapeutics has announced the closing of an oversubscribed $115 million Series B financing round. >> Click here for more funding data on Expedition Therapeutics >> To export Expedition Therapeutic...
Aug 5, 2026Expedition Therapeutics Raises $115M in Series B FundingExpedition Therapeutics, a San Francisco, CA-based clinical-stage biotechnology platform, raised $115M in Series B financing. The round was led by General Atlantic with participation from RA Capital, Vivo Capital, Sofinnova Investments, Nov...
Aug 3, 2026Claris Biotherapeutics Raises $118M in Series B FundingClaris Biotherapeutics, Inc., a Jersey City, NJ-based biopharmaceutical company developing therapies for sight-threatening conditions, raised $118M in Series B financing. The round was led by Samsara Biocapital and Catalio Capital Managemen...
Jun 29, 2026Lycia Therapeutics Raises $75 Million Series D To Advance LYTAC PipelineLycia Therapeutics announced that it has completed an oversubscribed $75 million Series D financing. The financing was co-led by existing investor Janus Henderson Investors and new investor Balyasny Asset Management. The round also included...
Jun 29, 2026Lycia Therapeutics Raises $75M in Series D FundingLycia Therapeutics, a South San Francisco, California-based developer of extracellular protein degradation and lysosomal targeting chimera (LYTAC) therapeutics, raised $75m in Series D funding. The round was co-led by Janus Henderson Invest...
Oct 10, 2025Expedition Therapeutics Raises $165M in FundingExpedition Therapeutics, a San Francisco, CA-based biotech company developing therapies for novel inflammatory and respiratory diseases, raised $165M in Series A financing. The round was led by Sofinnova Investments and Novo Holdings, with ...
Oct 9, 2025Expedition resupplies for phase 2 COPD voyage with $165M series AExpedition Therapeutics is gearing up for a phase 2 trek with a $165 million series A that closed Oct. 9. The new funding will fuel the Bay Area biotech’s DPP1 inhibitor EXPD-101 as it ventures into a study in patients with chronic obstruct...
Oct 9, 2025Expedition Therapeutics: $165 Million Series A Raised For Advancing DPP1 Inhibitor For COPDExpedition Therapeutics, a biotechnology company dedicated to developing therapies for novel inflammatory and respiratory diseases, has closed an oversubscribed and upsized Series A financing round, raising $165 million. This financing roun...
Sep 10, 2025Quantum Leap: PsiQuantum Secures $1 Billion, Partners With NvidiaPsiQuantum, a leader in quantum computing, just secured $1 billion in Series E funding. This propels its valuation to $7 billion. A pivotal partnership with Nvidia was also announced. This collaboration accelerates the development of PsiQua...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Adage Capital Management

How many startups has Adage Capital Management invested in?

Adage Capital Management has 3 portfolio companies on Parsers VC, among them PsiQuantum and Equillium.

What has the press written about Adage Capital Management?

Parsers VC has collected 23 articles mentioning Adage Capital Management, among them “Expedition Therapeutics Lands $115M Series B” (Aug 9, 2026) and “Expedition Therapeutics Raises $115M in Series B Funding” (Aug 5, 2026).

Is Adage Capital Management still active?

Yes, Adage Capital Management is active; its latest activity on Parsers VC dates from Aug 10, 2026.